Drug Discovery Services Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

  • Published : Jan-2018
  • Tables : 173
  • Figures : 111
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT375MR
  • Format : ppt

Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services. Introduction of advanced technology in the drug discovery process is also the major driver in the market growth. However, stringent regulations in some regions on drug discovery services, high cost involved in the discovery of drug and development and usage of animals in testing are hampering the market growth.

global drug discovery services market

According to a study by Fact.MR, the global market for drug discovery services is likely to experience strong growth. By 2026 end, the global market for drug discovery services is also estimated to bring in US$ 16,800.1 million revenue. Advancements in the drug discovery technologies are leading to the better drug discovery services. Some of the upcoming trends in the market in terms of drug discovery technology are regulatory initiatives towards pharmacogenomics technology, combinatorial chemistry technology, etc. there has also been an increase in the adoption of label-free techniques.

Market Taxonomy

Process 

Type

Drug Type

Therapeutic Area

Target Selection

Medicinal Chemistry

Small Molecules

Oncology

Target Validation

Biology Services

Biologics

Neurology

Hit-To-Lead Identification

Drug Metabolism and Pharmacokinetics

 

Cardiovascular Diseases

Lead Optimization

 

 

Respiratory Diseases

Candidate Validation

 

 

Diabetes

 

 

 

Other Therapeutic Areas

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Hit-To-Lead Identification to Gain Maximum Traction 

Compared to the various processes in the drug discovery services, Hit-To-Lead identification is anticipated to gain maximum traction. Hit-To-Lead identification is likely to exceed US$ 6,900 million revenue towards 2026 end. Increasing research based on the High-Throughput Screening (HTS) is the main factor driving the use of hit-to-lead identification process.

Medicinal Chemistry to be the Largest Type of Drug Discovery Services

Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.

Small Molecules to Witness Highest Growth in Terms of Revenue

Compared to biologics, small molecules are estimated to account for the highest share in terms of revenue. By 2026 end, small molecules are estimated to exceed US$ 10,800 million revenue. Small molecules are gaining traction as they are easy to characterize, simple and well defined. Also, small molecules can easily enter cells, and can cause cancer cells to die.

Oncology to Hold Largest Revenue Share in the Therapeutic Area

By therapeutic area, oncology is likely to emerge as the largest segment throughout the forecast period. Towards 2026 end, oncology is estimated to exceed US$ 6,900 million revenue. Increasing number of people suffering from cancer is resulting in the high demand for cancer therapies. Hence, oncology is anticipated to experience a significant growth in the coming years.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global drug discovery services market through 2026, which include Syngene, Wuxi Apptec, Aurigene Discovery Technologies, Genscript Biotech Corporation, Covance, Jubilant Biosys, Pharmaceutical Product Development, LLC. (Ppd), Evotec, Charles River Laboratories International, Albany Molecular Research, Inc. (AMRI), GE Healthcare, Merck Millipore, and Thermo Fisher Scientific, Inc.

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.M

1. Global Economic Outlook

2. Global Drug Discovery Services Market - Executive Summary

3. Global Drug Discovery Services Market Overview
3.1. Introduction
       3.1.1. Global Drug Discovery Services Market Taxonomy
       3.1.2. Global Drug Discovery Services Market Definition
3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Drug Discovery Services Market Y-o-Y Growth
3.3. Global Drug Discovery Services Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTL Analysis 
3.7. Product Life Cycle Analysis
3.8. Drug Discovery & Development Process
3.9. Roadmap to Optimize Regulatory and Commercial Success
3.10. Evolution of R&D Drug Discovery Outsourcing
3.11. Service Provider List
3.12. Key Participants Market Presence (Intensity Map) By Region

4. Global Drug Discovery Services Market Analysis and Forecast 2012-2026 
4.1. Global Drug Discovery Services Market Size and Forecast By Process , 2012-2026
       4.1.1. Target Selection Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Target Validation Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Hit-To-Lead Identification Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Lead Optimization Market Size and Forecast, 2012-2026
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
       4.1.5. Candidate Validation Market Size and Forecast, 2012-2026
                4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                4.1.5.2. Market Share Comparison, By Region
                4.1.5.3. Y-o-Y growth Comparison, By Region
4.2. Global Drug Discovery Services Market Size and Forecast By Type, 2012-2026
       4.2.1. Medicinal Chemistry Market Size and Forecast, 2012-2026
                4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                4.2.1.2. Market Share Comparison, By Region
                4.2.1.3. Y-o-Y growth Comparison, By Region
       4.2.2. Biology Services Market Size and Forecast, 2012-2026
                4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                4.2.2.2. Market Share Comparison, By Region
                4.2.2.3. Y-o-Y growth Comparison, By Region
       4.2.3. Drug Metabolism and Pharmacokinetics Market Size and Forecast, 2012-2026
                4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                4.2.3.2. Market Share Comparison, By Region
                4.2.3.3. Y-o-Y growth Comparison, By Region
4.3. Global Drug Discovery Services Market Size and Forecast By Drug Type, 2012-2026
       4.3.1. Small Molecules Market Size and Forecast, 2012-2026
                4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                4.3.1.2. Market Share Comparison, By Region
                4.3.1.3. Y-o-Y growth Comparison, By Region
       4.3.2. Biologics Market Size and Forecast, 2012-2026
                4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                4.3.2.2. Market Share Comparison, By Region
                4.3.2.3. Y-o-Y growth Comparison, By Region
4.4. Global Drug Discovery Services Market Size and Forecast By Therapeutic Area, 2012-2026
       4.4.1. Oncology Market Size and Forecast, 2012-2026
                4.4.1.1. Revenue (US$ Mn) Comparison, By Region
                4.4.1.2. Market Share Comparison, By Region
                4.4.1.3. Y-o-Y growth Comparison, By Region
       4.4.2. Neurology Market Size and Forecast, 2012-2026
                4.4.2.1. Revenue (US$ Mn) Comparison, By Region
                4.4.2.2. Market Share Comparison, By Region
                4.4.2.3. Y-o-Y growth Comparison, By Region
       4.4.3. Respiratory Diseases Market Size and Forecast, 2012-2026
                4.4.3.1. Revenue (US$ Mn) Comparison, By Region
                4.4.3.2. Market Share Comparison, By Region
                4.4.3.3. Y-o-Y growth Comparison, By Region
       4.4.4. Respiratory Diseases Market Size and Forecast, 2012-2026
                4.4.4.1. Revenue (US$ Mn) Comparison, By Region
                4.4.4.2. Market Share Comparison, By Region
                4.4.4.3. Y-o-Y growth Comparison, By Region
       4.4.5. Diabetes Market Size and Forecast, 2012-2026
                4.4.5.1. Revenue (US$ Mn) Comparison, By Region
                4.4.5.2. Market Share Comparison, By Region
                4.4.5.3. Y-o-Y growth Comparison, By Region
       4.4.6. Other Therapeutic Areas Market Size and Forecast, 2012-2026
                4.4.6.1. Revenue (US$ Mn) Comparison, By Region
                4.4.6.2. Market Share Comparison, By Region
                4.4.6.3. Y-o-Y growth Comparison, By Region

5. North America Drug Discovery Services Market Size and Forecast, 2012-2026
5.1. North America Outlook 
5.2. North America Parent Market Outlook 
5.3. North America Target Market Outlook 
5.4. Revenue (US$ Mn) Comparison, By Country 
       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Process  
5.6. Revenue (US$ Mn) Comparison, By Type 
5.7. Revenue (US$ Mn) Comparison, By Drug Type 
5.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

6. Latin America Drug Discovery Services Market Size and Forecast, 2012-2026
6.1. Latin America Outlook 
6.2. Latin America Parent Market Outlook 
6.3. Latin America Target Market Outlook 
6.4. Revenue (US$ Mn) Comparison, By Country 
       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Process  
6.6. Revenue (US$ Mn) Comparison, By Type 
6.7. Revenue (US$ Mn) Comparison, By Drug Type 
6.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

7. Europe Drug Discovery Services Market Size and Forecast, 2012-2026
7.1. Europe Outlook 
7.2. Europe Parent Market Outlook 
7.3. Europe Target Market Outlook 
7.4. Revenue (US$ Mn) Comparison, By Country 
       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Process  
7.6. Revenue (US$ Mn) Comparison, By Type 
7.7. Revenue (US$ Mn) Comparison, By Drug Type 
7.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

8. Japan Drug Discovery Services Market Size and Forecast, 2012-2026
8.1. Japan Outlook 
8.2. Japan Parent Market Outlook 
8.3. Japan Target Market Outlook 
8.4. Revenue (US$ Mn) Comparison, By Country 
       8.4.1. Japan  Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Process  
8.6. Revenue (US$ Mn) Comparison, By Type 
8.7. Revenue (US$ Mn) Comparison, By Drug Type 
8.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

9. APEJ Drug Discovery Services Market Size and Forecast, 2012-2026
9.1. APEJ Outlook 
9.2. APEJ Parent Market Outlook 
9.3. APEJ Target Market Outlook 
9.4. Revenue (US$ Mn) Comparison, By Country 
       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
       9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
       9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
       9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Process  
9.6. Revenue (US$ Mn) Comparison, By Type 
9.7. Revenue (US$ Mn) Comparison, By Drug Type 
9.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

10. MEA Drug Discovery Services Market Size and Forecast, 2012-2026
10.1. MEA Outlook 
10.2. MEA Parent Market Outlook 
10.3. MEA Target Market Outlook 
10.4. Revenue (US$ Mn) Comparison, By Country 
       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
       10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Process  
10.6. Revenue (US$ Mn) Comparison, By Type 
10.7. Revenue (US$ Mn) Comparison, By Drug Type 
10.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

11. Global Drug Discovery Services Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
       11.3.1. Thermo Fisher Scientific, Inc.
       11.3.2. GE Healthcare
       11.3.3. Charles River Laboratories International
       11.3.4. Agilent Technologies, Inc.
       11.3.5. Eli Lilly and Company
       11.3.6. Lonza Group Ltd
       11.3.7. WuXi AppTec Co., Ltd.
       11.3.8. Evotec AG
       11.3.9. Pharmaceutical Product Development LLC
       11.3.10. Merck Millipore 
       11.3.11. Albany Molecular Research, Inc.
       11.3.12. Covance Inc.
       11.3.13. Genscript Biotech Corporation
       11.3.14. Aurigene Discovery Technologies Limited
       11.3.15. Syngene International Limited
       11.3.16. Promega Corporation
       11.3.17. SRI International, Inc.
       11.3.18. Chembridge Corporation
       11.3.19. GVK Biosciences Private Limited
       11.3.20. Domainex Ltd.
       11.3.21. Selcia Limited
       11.3.22. Viva Biotech Ltd.
       11.3.23. Jubilant Biosys Limited
       11.3.24. Ubiquigent Limited
       11.3.25. ReproCELL, Inc.
       11.3.26. DiscoverX Corporation
       11.3.27. Creative Bioarray
11.4. Key Takeaways

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

TABLE 1 Global Drug Discovery Services Market Value (US$ Mn), 2012-2017
TABLE 2 Global Drug Discovery Services Market Value (US$ Mn), 2018-2026
TABLE 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Target Selection Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Target Selection Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Target Selection Segment Market Share, By Region 2012-2017
TABLE 7 Global Target Selection Segment Market Share, By Region 2018-2026
TABLE 8 Global Target Selection Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Target Validation Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Target Validation Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Target Validation Segment Market Share, By Region 2012-2017
TABLE 12 Global Target Validation Segment Market Share, By Region 2018-2026
TABLE 13 Global Target Validation Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Hit-To-Lead Identification Segment Market Share, By Region 2012-2017
TABLE 17 Global Hit-To-Lead Identification Segment Market Share, By Region 2018-2026
TABLE 18 Global Hit-To-Lead Identification Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Lead Optimization Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Lead Optimization Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Lead Optimization Segment Market Share, By Region 2012-2017
TABLE 22 Global Lead Optimization Segment Market Share, By Region 2018-2026
TABLE 23 Global Lead Optimization Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Candidate Validation Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Candidate Validation Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Candidate Validation Segment Market Share, By Region 2012-2017
TABLE 27 Global Candidate Validation Segment Market Share, By Region 2018-2026
TABLE 28 Global Candidate Validation Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Medicinal Chemistry Segment Market Share, By Region 2012-2017
TABLE 32 Global Medicinal Chemistry Segment Market Share, By Region 2018-2026
TABLE 33 Global Medicinal Chemistry Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Biology Services Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Biology Services Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Biology Services Segment Market Share, By Region 2012-2017
TABLE 37 Global Biology Services Segment Market Share, By Region 2018-2026
TABLE 38 Global Biology Services Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2012-2017
TABLE 42 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2018-2026
TABLE 43 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Small Molecules Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Small Molecules Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Small Molecules Segment Market Share, By Region 2012-2017
TABLE 47 Global Small Molecules Segment Market Share, By Region 2018-2026
TABLE 48 Global Small Molecules Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Biologics Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Biologics Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Biologics Segment Market Share, By Region 2012-2017
TABLE 52 Global Biologics Segment Market Share, By Region 2018-2026
TABLE 53 Global Biologics Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Oncology Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Oncology Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Oncology Segment Market Share, By Region 2012-2017
TABLE 57 Global Oncology Segment Market Share, By Region 2018-2026
TABLE 58 Global Oncology Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Neurology Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Neurology Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Neurology Segment Market Share, By Region 2012-2017
TABLE 62 Global Neurology Segment Market Share, By Region 2018-2026
TABLE 63 Global Neurology Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Cardiovascular Diseases Segment Market Share, By Region 2012-2017
TABLE 67 Global Cardiovascular Diseases Segment Market Share, By Region 2018-2026
TABLE 68 Global Cardiovascular Diseases Segment Y-o-Y, By Region 2017-2026
TABLE 69 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2012-2017
TABLE 70 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2018-2026
TABLE 71 Global Respiratory Diseases Segment Market Share, By Region 2012-2017
TABLE 72 Global Respiratory Diseases Segment Market Share, By Region 2018-2026
TABLE 73 Global Respiratory Diseases Segment Y-o-Y, By Region 2017-2026
TABLE 74 Global Diabetes Segment Value (US$ Mn), By Region 2012-2017
TABLE 75 Global Diabetes Segment Value (US$ Mn), By Region 2018-2026
TABLE 76 Global Diabetes Segment Market Share, By Region 2012-2017
TABLE 77 Global Diabetes Segment Market Share, By Region 2018-2026
TABLE 78 Global Diabetes Segment Y-o-Y, By Region 2017-2026
TABLE 79 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2012-2017
TABLE 80 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2018-2026
TABLE 81 Global Other Therapeutic Areas Segment Market Share, By Region 2012-2017
TABLE 82 Global Other Therapeutic Areas Segment Market Share, By Region 2018-2026
TABLE 83 Global Other Therapeutic Areas Segment Y-o-Y, By Region 2017-2026
TABLE 84 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 85 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 86 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 87 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 88 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 89 North America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
TABLE 90 North America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
TABLE 91 North America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
TABLE 92 North America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
TABLE 93 North America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
TABLE 94 North America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
TABLE 95 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 96 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 97 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
TABLE 98 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
TABLE 99 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 100 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 101 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 102 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 103 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 104 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
TABLE 105 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
TABLE 106 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
TABLE 107 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
TABLE 108 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
TABLE 109 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
TABLE 110 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 111 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 112 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
TABLE 113 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
TABLE 114 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 115 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 116 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 117 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 118 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 119 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
TABLE 120 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
TABLE 121 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
TABLE 122 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
TABLE 123 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
TABLE 124 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
TABLE 125 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 126 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 127 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
TABLE 128 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
TABLE 129 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 130 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 131 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 132 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 133 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 134 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
TABLE 135 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
TABLE 136 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
TABLE 137 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
TABLE 138 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
TABLE 139 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
TABLE 140 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 141 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 142 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
TABLE 143 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
TABLE 144 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 145 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 146 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 147 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 148 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 149 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
TABLE 150 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
TABLE 151 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
TABLE 152 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
TABLE 153 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
TABLE 154 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
TABLE 155 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 156 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 157 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
TABLE 158 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
TABLE 159 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 160 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 161 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 162 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 163 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 164 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
TABLE 165 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
TABLE 166 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
TABLE 167 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
TABLE 168 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
TABLE 169 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
TABLE 170 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 171 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 172 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
TABLE 173 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026

FIG. 1 Global Drug Discovery Services Market Value (US$ Mn), 2012-2017
FIG. 2 Global Drug Discovery Services Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Target Selection Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Target Selection Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Target Validation Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Target Validation Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Hit-To-Lead Identification Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Lead Optimization Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Candidate Validation Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Medicinal Chemistry Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Biology Services Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Biology Services Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Biology Services Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Small Molecules Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Biologics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Biologics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Oncology Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Oncology Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Oncology Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Neurology Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Neurology Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Neurology Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Cardiovascular Diseases Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 44 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 45 Global Respiratory Diseases Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 46 Global Diabetes Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 47 Global Diabetes Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 48 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 49 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 50 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 51 Global Other Therapeutic Areas Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 52 North America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
FIG. 53 North America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
FIG. 54 North America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
FIG. 55 North America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
FIG. 56 North America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
FIG. 57 North America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
FIG. 58 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 59 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 60 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
FIG. 61 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
FIG. 62 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
FIG. 63 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
FIG. 64 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
FIG. 65 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
FIG. 66 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
FIG. 67 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
FIG. 68 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 69 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 70 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
FIG. 71 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
FIG. 72 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
FIG. 73 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
FIG. 74 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
FIG. 75 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
FIG. 76 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
FIG. 77 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
FIG. 78 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 79 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 80 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
FIG. 81 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
FIG. 82 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
FIG. 83 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
FIG. 84 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
FIG. 85 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
FIG. 86 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
FIG. 87 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
FIG. 88 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 89 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 90 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
FIG. 91 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
FIG. 92 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
FIG. 93 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
FIG. 94 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
FIG. 95 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
FIG. 96 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
FIG. 97 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
FIG. 98 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 99 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 100 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
FIG. 101 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
FIG. 102 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
FIG. 103 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
FIG. 104 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
FIG. 105 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
FIG. 106 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
FIG. 107 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
FIG. 108 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 109 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 110 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
FIG. 111 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development